Journal profile · Pathology
Brain Tumor Pathology
ISSN 1433-7398 · eISSN 1861-387X · Springer Singapore · JAPAN · Semiannual · Founded 1997
Brain Tumor Pathology: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.19; hybrid open access; APC about USD 4,290; median 142 days to acceptance (55 articles, last 24 months); community-reported acceptance: fairly easy; 28 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Brain Tumor Pathology is published by Springer Singapore and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Glioma Diagnosis and Treatment, Meningioma and schwannoma management and Neurofibromatosis and Schwannoma Cases, together about 47% of its articles. Its main subfields are Neurology. (generated from OpenAlex topic counts and CAS ranking data)
Brain Tumor Pathology is the official journal of the Japan Society of Brain Tumor Pathology. This international journal documents the latest research and topical debate in all clinical and experimental fields relating to brain tumors, especially brain tumor pathology. The journal has been published since 1983 and has been recognized worldwide as a unique journal of high quality. The journal welcomes the submission of manuscripts from any country. Membership in the society is not a prerequisite for submission. The journal publishes original articles, case reports, rapid short communications, instructional lectures, review articles, letters to the editor, and topics.Review articles and Topics may be recommended at the annual meeting of the Japan Society of Brain Tumor Pathology. All contributions should be aimed at promoting international scientific collaboration.
From the journal's Aims & Scope
Research area (LetPub): Pathology
Editor-in-chief Yuichi HirosePublisher website
Editorial board by country: none in mainland China; most named Japan 75 (75 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Glioma Diagnosis and TreatmentMedicine31.2%
- Meningioma and schwannoma managementMedicine9.3%
- Neurofibromatosis and Schwannoma CasesMedicine6.5%
- Neuroblastoma Research and TreatmentsMedicine5.7%
- Brain Metastases and TreatmentMedicine5.2%
- Sarcoma Diagnosis and TreatmentMedicine3.8%
- Chromatin Remodeling and CancerBiochemistry, Genetics and Molecular Biology3.3%
- Vascular Malformations Diagnosis and TreatmentMedicine2.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Clinical Neurology | Zone 3 |
| Minor | Pathology | Zone 3 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
| Minor | Clinical Neurology | Zone 3 |
| Minor | Pathology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Clinical Neurology | Zone 3 |
| Minor | Pathology | Zone 3 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.19LetPub ·
- Impact factor (publisher) 2025
- 2.2Publisher website ·
- 5-year impact factor (publisher) 2025
- 2.2Publisher website ·
- CiteScore 2026-06
- 4.5LetPub ·
- SJR 2026-06
- 0.62LetPub ·
- SNIP 2026-06
- 0.92LetPub ·
- h-index
- 34LetPub ·
- h-index
- 55OpenAlex ·
- i10-index
- 465OpenAlex ·
- 2-year mean citedness
- 1.36OpenAlex ·
- Self-citation rate
- 4.5%LetPub ·
- Share of gold OA articles
- 32.26%LetPub ·
Volume
- Articles per year
- 25LetPub ·
- Downloads per year (publisher) 2025
- 102,100Publisher website ·
Articles by year OpenAlex count · 843 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 25 | 10 | 0 |
| 2025 | 28 | 11 | 24 |
| 2024 | 19 | 9 | 74 |
| 2023 | 27 | 12 | 189 |
| 2022 | 30 | 7 | 314 |
| 2021 | 30 | 7 | 408 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
142 daysMedian, submission to acceptance · P25–P75 106 days – 177 days
- Acceptance to online
- median 18 days (55 articles)
- Submission to online
- median 161 days
- Sample
- 55 articles with submission and acceptance dates (56 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Submission to first decision
- 23 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,290 / EUR 3,390 / GBP 2,890 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 200 words
- Keywords
- ≥ 3
- Manuscript length
- ≤ 6,400 words
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
- Cover letter
- Required
Article types accepted1, with length limits
- letterials & methods, results and discussion. Letters must not exceed 1,600 words in total with no more than two figures (or tables). No moremain text ≤ 1,600 words
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, License & copyright, Open access
- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data availability statements
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Brain Tumor Pathology, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Singapore
- Country or region
- JAPAN
- Language
- English
- Frequency
- Semiannual
- Founded
- 1997
- ISSN
- 1433-7398
- Electronic ISSN
- 1861-387X
- Latest issue on the website
- Volume 43, Issue 3 (July 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
FAQ
Frequently asked questions about Brain Tumor Pathology
What CAS zone is Brain Tumor Pathology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Brain Tumor Pathology is in Zone 3 of Medicine, and in Zone 3 of the minor category Clinical Neurology / Pathology / Oncology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Brain Tumor Pathology?
The latest impact factor listed by LetPub is 2.19; CiteScore 4.5, h-index 55.
How long does peer review take at Brain Tumor Pathology?
Based on the dates recorded on 55 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 142 days (interquartile range 106–177 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Brain Tumor Pathology?
According to the journal's author guidelines: Abstract: ≤ 200 words; Keywords: ≥ 3; Manuscript length: ≤ 6,400 words; Reference style: Numbered, in order of citation; Suggested reviewers: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Brain Tumor Pathology based?
Of the 75 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Japan (75). Counted from the institutions listed on the board page; for reference only.
Which databases index Brain Tumor Pathology?
According to LetPub and DOAJ records, Brain Tumor Pathology is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase, CAS and Current Contents; that list has not been checked against each database.
Is Brain Tumor Pathology open access, and what is the APC?
Brain Tumor Pathology is a hybrid journal. For open-access publication: APC about USD 4,290.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .